VSY Biotechnology BV and Carl Zeiss Meditec AG Settled Their Legal Disputes
AMSTERDAM, Feb. 15, 2019 /PRNewswire/ --
VSY Biotechnology BV and Carl Zeiss Meditec AG jointly announced that both companies resolved their legal and patent disputes with respect to Tri-ED 611. The companies agreed not to disclose the terms of the settlement.
SOURCE VSY Biotechnology BV
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
Newsrooms &
Influencers
9k+
Digital Media
Outlets
Digital Media
Outlets
270k+
Journalists
Opted In
Journalists
Opted In
Share this article